Cargando…
Should Denosumab or Radical Surgery Be Recommended for a Spinal Giant Cell Tumour in a Fertile Female?
Giant cell tumour (GCT) of the spine is a benign aggressive tumour with high recurrence rates. Patients can be asymptomatic due to the slow growth rate and present with localized pain or neurological dysfunction. Current management strategies include intralesional curettage, total en-bloc resection...
Autores principales: | Rajgor, Harshadkumar Dhirajlal, James, Steven, Botchu, Rajesh, Grainger, Melvin, Czyz, Marcin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746321/ https://www.ncbi.nlm.nih.gov/pubmed/33354470 http://dx.doi.org/10.7759/cureus.11526 |
Ejemplares similares
-
The impact of a spinal best practice tariff on compliance with the British Spine Registry
por: Habeebullah, Awais, et al.
Publicado: (2021) -
Factors Influencing Surgical Outcomes for Intradural Spinal Tumours: A Single-Centre Retrospective Cohort Study
por: Soon, Wai C, et al.
Publicado: (2022) -
The Decalcification of Cervicothoracic Spinal Metastasis of Breast Cancer Due to Discontinuation of Denosumab: A Case Report
por: Tatsumura, Masaki, et al.
Publicado: (2022) -
Is Surgical Training Prepared for the “Second Wave” of COVID-19? A Collaborative Perspective
por: Rajgor, Harshadkumar Dhirajlal, et al.
Publicado: (2021) -
Separation Surgery, Fixation With Carbon-Fiber Implants, and Stereotactic Body Radiotherapy for Oligometastatic Spinal Disease
por: Galloway, Richard, et al.
Publicado: (2022)